TB (Even Resistant Cases)

Tuberculosis remains a significant public health challenge. Timely diagnosis and appropriate treatment, especially in drug-resistant cases, are vital for recovery and prevention of transmission.

Key Highlights:

  • Use of molecular tests (CBNAAT, LPA) for early detection
  • Tailored drug regimens for MDR/XDR-TB
  • Adherence support to prevent resistance
  • Regular follow-ups and side-effect management
  • Coordination with national TB programs and notification protocols

FAQs

What is tuberculosis?

TB is a bacterial infection primarily affecting the lungs, spread through the air when a person with active TB coughs or sneezes.

What is drug-resistant TB?

It refers to TB that does not respond to standard anti-TB drugs, requiring special medications and longer treatment.

How long does TB treatment last?

Standard TB treatment usually lasts 6 months, while drug-resistant TB can take 9–24 months depending on severity.

Is TB contagious?

Yes, active pulmonary TB is contagious. Treatment reduces this risk within a few weeks.

Can TB come back after treatment?

Relapse is possible if treatment is incomplete or immunity is weakened, but regular follow-up reduces this risk.